Harpreet Singh is the founder of immatics biotechnologies. immatics biotechnologies has raised $312M in total funding. Latest round: Other Equity.
Harpreet Singh is the co-founder of Immatics Biotechnologies, a clinical-stage biopharmaceutical company specializing in the discovery and development of T-cell redirecting cancer immunotherapies. Immatics Biotechnologies operates from Tuebingen, Germany, and Houston, Texas. The company has raised over $312 million in funding across multiple rounds.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide